You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (23) |
Back to Search
Adverse events of SGLT2 inhibitors associated with Health Canada safety warnings: An overview of quantitative systematic reviews.
- At: PSWC2020 (2020)
- Type: Poster
- By: ALKABBANI, Wajd (University of Waterloo, School of Pharmacy, Canada)
- Co-author(s): Wajd Alkabbani: School of Pharmacy, University of Waterloo, Kitchener, Canada
Ryan Pelletier: School of Pharmacy, University of Waterloo, Kitchener, Canada
Kelvin Ng: School of Pharmacy, University of Waterloo, Kitchener, Canada
Youssef Labib: School of Pharmacy, University of Waterloo, Kitchener, Canada
Nicolas Mourad: School of Pharmacy, University of Waterloo, Kitchener, Canada
John-Michael Gamble: School of Pharmacy, University of Waterloo, Kitchener, Canada - Abstract:
Background
The introduction of the sodium glucose co-transporter-2 (SGLT2) inhibitors was followed by safety warnings by Health Canada.Purpose
Summarize and assess the quality of evidence around adverse events of canagliflozin, dapagliflozin, and empagliflozin, for which a safety warning was issued.Methods
We searched PubMed, EMBASE and the.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026